Literature DB >> 15038603

Role of oxidative damage in Friedreich's ataxia.

J L Bradley1, S Homayoun, P E Hart, A H V Schapira, J M Cooper.   

Abstract

Plasma malondialdehyde (MDA) levels were raised in Friedreich's ataxia (FRDA) patients. These levels correlated with increasing age and disease duration, suggesting lipid peroxidation increased with disease progression. Using fibroblasts from FRDA patients we observed that GSH levels and aconitase activities were normal, suggesting their antioxidant status was unchanged. When exposed to various agents to increase free radical generation we observed that intracellular superoxide generation induced by paraquat caused enhanced oxidative damage. This correlated with the size of the GAA1 expansion, suggesting decreased frataxin levels may render the cells more vulnerable to mild oxidative stress. More severe oxidative stress induced by hydrogen peroxide caused increased cell death in FRDA fibroblasts but was not significantly different from control cells. We propose that abnormal respiratory chain function and iron accumulation may lead to a progressive increase in oxidative damage, but increased sensitivity to free radicals may not require detectable respiratory chain dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15038603     DOI: 10.1023/b:nere.0000014826.00881.c3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

1.  Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria.

Authors:  F Foury; O Cazzalini
Journal:  FEBS Lett       Date:  1997-07-14       Impact factor: 4.124

2.  Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia.

Authors:  Patrizia Cavadini; Heather A O'Neill; Oldrich Benada; Grazia Isaya
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

3.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.

Authors:  V Campuzano; L Montermini; Y Lutz; L Cova; C Hindelang; S Jiralerspong; Y Trottier; S J Kish; B Faucheux; P Trouillas; F J Authier; A Dürr; J L Mandel; A Vescovi; M Pandolfo; M Koenig
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

4.  Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

Authors:  R Lodi; J M Cooper; J L Bradley; D Manners; P Styles; D J Taylor; A H Schapira
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not.

Authors:  A Hausladen; I Fridovich
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

6.  Clinical and genetic abnormalities in patients with Friedreich's ataxia.

Authors:  A Dürr; M Cossee; Y Agid; V Campuzano; C Mignard; C Penet; J L Mandel; A Brice; M Koenig
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

7.  Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.

Authors:  A E Harding
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

Review 8.  Lipid peroxidation: its mechanism, measurement, and significance.

Authors:  B Halliwell; S Chirico
Journal:  Am J Clin Nutr       Date:  1993-05       Impact factor: 7.045

9.  Paraquat damage of rat liver mitochondria by superoxide production depends on extramitochondrial NADH.

Authors:  K Hirai; K Ikeda; G Y Wang
Journal:  Toxicology       Date:  1992       Impact factor: 4.221

10.  A non-essential function for yeast frataxin in iron-sulfur cluster assembly.

Authors:  Geoffrey Duby; Françoise Foury; Anna Ramazzotti; Johannes Herrmann; Thomas Lutz
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

View more
  21 in total

1.  PEP-1-frataxin significantly increases cell proliferation and neuroblast differentiation by reducing lipid peroxidation in the mouse dentate gyrus.

Authors:  Woosuk Kim; Dae Won Kim; Bich Na Shin; Dae Young Yoo; Sung Min Nam; Mi Jin Kim; Jung Hoon Choi; Yeo Sung Yoon; Moo-Ho Won; Soo Young Choi; In Koo Hwang
Journal:  Neurochem Res       Date:  2011-09-01       Impact factor: 3.996

2.  Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.

Authors:  Belén Mollá; Diana C Muñoz-Lasso; Pablo Calap; Angel Fernandez-Vilata; María de la Iglesia-Vaya; Federico V Pallardó; Maria Dolores Moltó; Francesc Palau; Pilar Gonzalez-Cabo
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

3.  γ-Glutamylcysteine ameliorates oxidative injury in neurons and astrocytes in vitro and increases brain glutathione in vivo.

Authors:  Truc M Le; Haiyan Jiang; Gary R Cunningham; Jordan A Magarik; William S Barge; Marilyn C Cato; Marcelo Farina; Joao B T Rocha; Dejan Milatovic; Eunsook Lee; Michael Aschner; Marshall L Summar
Journal:  Neurotoxicology       Date:  2010-12-13       Impact factor: 4.294

Review 4.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

5.  Diametrically opposed effects of hypoxia and oxidative stress on two viral transactivators.

Authors:  Amber T Washington; Gyanendra Singh; Ashok Aiyar
Journal:  Virol J       Date:  2010-05-10       Impact factor: 4.099

Review 6.  Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity.

Authors:  Vittorio Calabrese; Carolin Cornelius; Cesare Mancuso; Giovanni Pennisi; Stella Calafato; Francesco Bellia; Timothy E Bates; Anna Maria Giuffrida Stella; Tony Schapira; Albena T Dinkova Kostova; Enrico Rizzarelli
Journal:  Neurochem Res       Date:  2008-07-16       Impact factor: 3.996

7.  G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization.

Authors:  Tatiana D Papkovskaia; Kai-Yin Chau; Francisco Inesta-Vaquera; Dmitri B Papkovsky; Daniel G Healy; Koji Nishio; James Staddon; Michael R Duchen; John Hardy; Anthony H V Schapira; J Mark Cooper
Journal:  Hum Mol Genet       Date:  2012-06-26       Impact factor: 6.150

8.  Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia.

Authors:  Alain Martelli; Lisa S Friedman; Laurence Reutenauer; Nadia Messaddeq; Susan L Perlman; David R Lynch; Kathrin Fedosov; Jörg B Schulz; Massimo Pandolfo; Hélène Puccio
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758

9.  Limitations in a frataxin knockdown cell model for Friedreich ataxia in a high-throughput drug screen.

Authors:  Nadège Calmels; Hervé Seznec; Pascal Villa; Laurence Reutenauer; Marcel Hibert; Jacques Haiech; Pierre Rustin; Michel Koenig; Hélène Puccio
Journal:  BMC Neurol       Date:  2009-08-24       Impact factor: 2.474

10.  Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology.

Authors:  Astrid C Haugen; Nicholas A Di Prospero; Joel S Parker; Rick D Fannin; Jeff Chou; Joel N Meyer; Christopher Halweg; Jennifer B Collins; Alexandra Durr; Kenneth Fischbeck; Bennett Van Houten
Journal:  PLoS Genet       Date:  2010-01-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.